FDA Banned From Approving More Generic Norvasc
A district court has banned the federal drug agency from granting new applications by generic drug makers to market cheap copies of Pfizer's popular Norvasc until it hears Mylan Laboratories' case...To view the full article, register now.
Already a subscriber? Click here to view full article